Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-15

Clinical Trial Update: Rapid Improvement of Depression of Fluoxetine Combined With ATP [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating rapid improvement of depression with fluoxetine combined with ATP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATP (adenosine triphosphate)
  • Fluoxetine (Fluoxetine)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Depression | Phase 2 | Status: UNKNOWN